Internal Medicine · Boston, MA
NPI
1508025933
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
Massachusetts General Hospital, 55 Fruit Street
Boston, MA, 02114
Phone (617) 726-2870
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
649 services
Medicare patients, 2024
247
Average age 73
Drug cost, 2024
$2.1M
1,313 prescriptions
Company payments, 2024
$4,680
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eli M Miloslavsky was code 99214 (office e&m - established), 155 times for 123 patients. In total Eli M Miloslavsky billed 649 services in 15 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 155 | 123 | $76.13 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 114 | 78 | $13.82 | $1,575 |
| 99232 Hospital E&M - Subsequent | Facility | 85 | 30 | $65.37 | $5,556 |
| 99214 Office E&M - Established | Office | 73 | 50 | $104.66 | $7,640 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 62 | 56 | $13.82 | $857 |
| 99215 Office E&M - Established | Facility | 41 | 36 | $120.85 | $4,955 |
| 99443 Telephone Services | Facility | 28 | 23 | $75.55 | $2,115 |
| 99215 Office E&M - Established | Office | 17 | 14 | $149.09 | $2,535 |
| 99238 Hospital Discharge Management | Facility | 13 | 13 | $67.92 | $883 |
By year: 2022 $45K for 585 services; 2023 $39K for 504 services; 2024 $42K for 649 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eli M Miloslavsky prescribed most often to Medicare patients was Prednisone, with 231 prescriptions and refills. In total Eli M Miloslavsky wrote 1,313 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 231 | 284 | 55 | $1,997 |
| Methotrexate Methotrexate Sodium | 142 | 281 | 37 | $3,515 |
| Hydroxychloroquine Sulfate Generic | 106 | 212 | 26 | $3,168 |
| Actemra Actpen Tocilizumab | 77 | 77 | 12 | $321K |
| Allopurinol Generic | 68 | 141 | 16 | $672 |
| Humira(Cf) Pen Adalimumab | 63 | 63 | Under 11 | $522K |
| Otezla Apremilast | 48 | 48 | Under 11 | $228K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 45 | Under 11 | $164 |
| Celecoxib Generic | 33 | 46 | Under 11 | $941 |
| Colchicine Generic | 28 | 54 | 11 | $1,808 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 24 | 24 | Under 11 | $218 |
| Cevimeline Hcl Generic | 23 | 45 | Under 11 | $4,858 |
| Kevzara Sarilumab | 23 | 23 | Under 11 | $96K |
| Mycophenolate Mofetil Generic | 21 | 49 | Under 11 | $8,496 |
| Alendronate Sodium Generic | 18 | 45 | Under 11 | $299 |
Brand drugs: 385 claims; generic drugs: 928 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Eli M Miloslavsky $4,680 ($4,680 in general payments such as food, travel and fees) from 1 company. The largest payer was Otsuka Pharmaceutical Development & Commercialization, Inc. with $4,680.
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $4,680 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.